Prognosis indicator in acute liver failure: Is there a place for cell death markers?

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 593-595

  Samuel, Didier ^a   Ichai, Philippe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYTOKERATIN 18; PARACETAMOL;

AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BUDD CHIARI SYNDROME; CELL DEATH; COMA; CONFUSION; DISEASE MARKER; DISEASE SEVERITY; DRUG INTOXICATION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; HEPATITIS A; HEPATITIS B; HUMAN; JAUNDICE; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MAYO END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT OUTCOME; WILSON DISEASE;

BIOLOGICAL MARKERS; CELL DEATH; HUMANS; LIVER FAILURE, ACUTE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 77956264433     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.002     Document Type: Editorial

References (14)

1. H. Bismuth, D. Samuel, D. Castaing, R. Adam, F. Saliba, and M. Johann Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience Ann Surg 222 1995 109 119
2. B. Brandsaeter, K. Hockerstedt, S. Friman, B.G. Ericzon, P. Kirkegaard, and H. Isoniemi Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries Liver Transplant 8 2002 1055 1062
3. G. Ostapowicz, R.J. Fontana, F.V. Schiodt, A. Larson, T.J. Davern, and S.H. Han Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954
4. P. Ichai, and D. Samuel Etiology and prognosis of fulminant hepatitis in adults Liver Transplant 14 2008 S67 S79
5. J.G. O'Grady, G.J. Alexander, K.M. Hayllar, and R. Williams Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439 445
6. W. Bernal, N. Donaldson, D. Wyncoll, and J. Wendon Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study Lancet 359 2002 558 563
7. J. Bernuau, B. Rueff, and J.P. Benhamou Fulminant and subfulminant liver failure: definitions and causes Semin Liver Dis 6 1986 97 106
8. X. Volkmann, M. Anstaett, J. Hadem, P. Stiefel, M.J. Bahr, and F. Lehner Caspase activation is associated with spontaneous recovery from acute liver failure Hepatology 47 2008 1624 1633
9. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.C. Ter Borg A model to predict poor survival in patients undergoing intrahepatic portosystemic shunts Hepatology 31 2000 864 871
10. R.H. Wiesner, E.B. Edwards, R.B. Freeman, A. Harper, R. Kim, and P. Kamath Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
11. S.E. Yantorno, W.K. Kremers, A.E. Ruf, J.J. Trentadue, L.G. Podesta, and F.G. Villamil MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure Liver Transplant 13 2007 822 828
12. R.K. Dhiman, S. Jain, U. Maheshwari, A. Bhalla, N. Sharma, and J. Ahluwalia Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King's College Hospital criteria Liver Transplant 13 2007 814 821
13. L.P. Bechmann, C. Jochum, P. Kocabayoglu, J.P. Sowa, M. Kassalik, and R.K. Gieseler Cytokeratin 18-based modification of the Meld score improves prediction of spontaneous survival after acute liver failure J Hepatol 53 2010 639 647
14. J.G. O'Grady, S.W. Schalm, and R. Williams Acute liver failure: redefining the syndromes Lancet 342 1993 273 275